HomePANG • BME
add
Pangaea Oncology SA
Previous close
€1.79
Year range
€1.68 - €1.91
Market cap
61.60M EUR
Avg Volume
489.00
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 3.77M | 139.72% |
Operating expense | 4.07M | 138.33% |
Net income | -799.85K | -73.96% |
Net profit margin | -21.19 | 27.43% |
Earnings per share | — | — |
EBITDA | -457.21K | -160.76% |
Effective tax rate | 5.56% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.86M | -63.32% |
Total assets | 26.87M | 5.54% |
Total liabilities | 9.95M | 77.36% |
Total equity | 16.92M | — |
Shares outstanding | 30.43M | — |
Price to book | 3.38 | — |
Return on assets | -7.25% | — |
Return on capital | -9.35% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -799.85K | -73.96% |
Cash from operations | -588.35K | -27.88% |
Cash from investing | -26.07K | 66.04% |
Cash from financing | 207.30K | 116.57% |
Net change in cash | -407.12K | 77.23% |
Free cash flow | 22.71K | 131.54% |
About
Founded
2006
Website
Employees
159
